Aberrant expression and association of VEGF and Dll4/notch pathway molecules under hypoxia in patients with lung cancer

Histology and Histopathology

Volumn 28, Issue 2, 2013, Pages 277-284

  Yu, Shuang ^a   Sun, Jianhua ^a,b   Zhang, Jingru ^a   Xu, Xingfang ^c   Li, Hong ^d   Shan, Baozhong ^d   Tian, Tian ^a   Wang, Hongchun ^a   Ma, Daoxin ^a   Ji, Chunyan ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c Department of Internal Medicine   (China)

^d JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Dll4; Lung cancer; Notch; VEGF

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD31 ANTIGEN; DLL4 PROTEIN, HUMAN; HES1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH RECEPTOR; SIGNAL PEPTIDE; VASCULOTROPIN A;

ADENOCARCINOMA; ADULT; AGED; ANOXIA; ARTICLE; CELL CULTURE; DISEASE COURSE; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; LUNG ADENOCARCINOMA; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UMBILICAL VEIN; UPREGULATION; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; ANTIGENS, CD31; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, NOTCH; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873830118     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Benedito R. and Duarte A. (2005). Expression of DLL4 during mouse embryogenesis suggests multiple developmental roles. Gene. Expr. Patterns. 5, 750-755.
2. Brekken R.A., Huang X., king S.W. and Thorpe P.E. (1998). Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res. 58, 1952-1959.
3. Ehebauer M., Hayward P. and Arias A.M. (2006). Notch, a universal arbiter of cell fate decisions. Science 314, 1414-1415.
4. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A., Adams N.C., Lin H.C., Holash J., Thurston G. and Yancopoulos G.D. (2004). Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101, 15949-15954.
5. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J.L., Poellinger L., Lendahl U. and Bondesson M. (2005). Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell. 9, 617-628.
6. Harris A.L. (2002). Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
7. Iso T., Hamamori Y. and Kedes L. (2003). Notch signaling in vascular development. Arterioscler. Thromb. Vasc. Biol. 23, 543-553.
8. Jain R.K., Duda D.G., Clark J.W. and Loeffler J.S. (2006). Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nature Clin. Pract. Oncol. 3, 24-40.
9. Kramer I. and Lipp H.P. (2007). Bevacizumab. a humanized antiangiogenic monoclonal antibody for the treatment of colorectal cancer. J. Clin. Pharm. 32, 1-14.
10. Li J.L. and Harris A.L. (2005). Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer. Cell. 8, 1-3.
11. Mailhos C., Lewis J., Horowicz D.I., Modlich U., Harris A. and Bicknell R. (2001). Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69, 135-144.
12. Marin V., Kaplanski G., Gres S., Farnarier C. and Bongrand P. (2001). Endothelial cell culture:protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Meth. 254, 183-190.
13. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., Lin H.C., Yancopoulos G.D. and Thurston G. (2006). Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037.
14. Patel N.S., Li J.L., Generali D., Poulsom R., Cranston D.W. and Harris A.L. (2005). Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 65, 8690-8697.
15. Roca C. and Adams R.H. (2007). Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 21, 2511-2524.
16. Shawber C.J. and Kitajwski J. (2004). Notch function in the vasculature: insights from zebrafish, mouse and man. Bio. Essays 26, 225-234.
17. Siekmann A.F. and Lawson N.D. (2007). Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781-784.
18. Suchting S., Freitas C., Noble F.L., Benedito R., Breant C., Duarte A. and Eichmann A. (2007). The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. USA 104, 3225-3230.
19. Taylor K.L., Henderson A.M. and Hughes C.C. (2002). Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc. Res. 64, 372-383.
20. Williams C.K., Li J.L., Murga M., Harris A.L. and Tosato G. (2006). Upregulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107, 931-939.